- Home
- BBIO vs OVBC Comparison
BBIO vs OVBC Comparison
Compare BBIO & OVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- OVBC
- Stock Information
- Founded
- BBIO 2015
- OVBC 1872
- Country
- BBIO United States
- OVBC United States
- Employees
- BBIO N/A
- OVBC N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- OVBC Major Banks
- Sector
- BBIO Health Care
- OVBC Finance
- Exchange
- BBIO Nasdaq
- OVBC Nasdaq
- Market Cap
- BBIO 6.7B
- OVBC N/A
- IPO Year
- BBIO 2019
- OVBC N/A
- Fundamental
- Price
- BBIO $34.17
- OVBC $37.00
- Analyst Decision
- BBIO Strong Buy
- OVBC
- Analyst Count
- BBIO 12
- OVBC 0
- Target Price
- BBIO $57.09
- OVBC N/A
- AVG Volume (30 Days)
- BBIO 3.1M
- OVBC 12.0K
- Earning Date
- BBIO 04-29-2025
- OVBC 04-25-2025
- Dividend Yield
- BBIO N/A
- OVBC 2.53%
- EPS Growth
- BBIO N/A
- OVBC N/A
- EPS
- BBIO N/A
- OVBC 2.32
- Revenue
- BBIO $127,415,000.00
- OVBC $59,506,000.00
- Revenue This Year
- BBIO $13.67
- OVBC N/A
- Revenue Next Year
- BBIO $118.02
- OVBC N/A
- P/E Ratio
- BBIO N/A
- OVBC $15.29
- Revenue Growth
- BBIO N/A
- OVBC 5.20
- 52 Week Low
- BBIO $21.62
- OVBC $19.35
- 52 Week High
- BBIO $39.47
- OVBC $40.99
- Technical
- Relative Strength Index (RSI)
- BBIO 44.19
- OVBC 58.60
- Support Level
- BBIO $33.92
- OVBC $33.90
- Resistance Level
- BBIO $39.16
- OVBC $38.75
- Average True Range (ATR)
- BBIO 1.50
- OVBC 1.68
- MACD
- BBIO -0.24
- OVBC -0.33
- Stochastic Oscillator
- BBIO 10.35
- OVBC 56.47
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.